Label: MYLANTA ONE ANTACID/ANTI-GAS- calcium carbonate, magnesium hydroxide, dimethicone tablet, chewable

  • NDC Code(s): 62372-552-50, 62372-552-51
  • Packager: Infirst Healthcare Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 11, 2023

If you are a consumer or patient please visit this version.

  • Active ingredients (in each tablet)

    Calcium carbonate 1000mg

    Magnesium hydroxide 270mg

    Simethicone 80mg

  • Purposes

    Antacid

    Antacid

    Anti-gas

  • Uses

    relieves:

    • heartburn
    • acid indigestion
    • sour stomach
    • upset stomach due to these symptoms
    • pressure and bloating commonly referred to as gas
    • overindulgence in food and drink
  • Warnings

    Ask a doctor before use if you have

    • kidney disease
    • a magnesium restricted diet

    Ask a doctor or pharmacist before use if you arepresently taking a prescription drug. Antacids may interact with certain prescription drugs.

  • Keep out of reach of children

    In case of overdose, get medical help or contact a poison control center right away at 1-800-222-1222.

  • Directions

    • adults and children 12 years and over:chew 1 tablet as symptoms occur, or as directed by doctor
    • do not take more than 6 tablets in 24 hours
    • do not use the maximum dosage for more than 2 weeks
    • children under 12 years of age:ask a doctor
  • Other information

    • each chewable tablet contains:calcium 400mg, magnesium 115mg
    • store between 20-25°C (68-77°F)
  • Inactive ingredients

    adipic acid, crospovidone, dextrose, FD&C Red #40 Lake, flavors, magnesium stearate, maltodextrin, sucralose

  • Questions?

    call 1-844-695-6624toll free (English and Spanish)


  • SPL UNCLASSIFIED SECTION

    Fast, powerful multi-symptom relief in a great-tasting ONE tablet dose.

    TAMPER-EVIDENT: DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING

    Mylanta ®is a Registered Trademark of McNeil Consumer Pharmaceuticals Co.

    Infirst Healthcare

    Manufactured for:
    Infirst Healthcare Inc.
    Westport, CT 06880.
    ©2021 Infirst Healthcare Inc.
    Mylanta.com

  • Package/Label Principal Display Panel

    Mylanta One Antacid/Anti-Gas chewable tablets - Berry Ginger - in plastic bottle

    NEW!

    3 POWERFUL INGREDIENTS IN ONE

    Mylanta ®
    ONE TM

    ANTACID + ANTI-GAS

    WORKS IN ONE TABLET

    WITH A SMOOTH SOOTHING TASTE!

    50 SINGLE DOSE CHEWABLE TABLETS

    BERRY
    GINGER

  • Package/Label Principal Display Panel

    Mylanta One Antacid/Anti-Gas chewable tablets - Berry Ginger - in EcoCare bottle

    3 POWERFUL INGREDIENTS IN ONE

    Mylanta ®
    ONE

    ANTACID + ANTI-GAS

    WORKS IN ONE TABLET

    WITH A SMOOTH SOOTHING TASTE!

    50 SINGLE DOSE CHEWABLE TABLETS

    BERRY
    GINGER

  • INGREDIENTS AND APPEARANCE
    MYLANTA ONE ANTACID/ANTI-GAS 
    calcium carbonate, magnesium hydroxide, dimethicone tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62372-552
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB, CARBONATE ION - UNII:7UJQ5OPE7D) CALCIUM CARBONATE1000 mg
    MAGNESIUM HYDROXIDE (UNII: NBZ3QY004S) (MAGNESIUM CATION - UNII:T6V3LHY838, HYDROXIDE ION - UNII:9159UV381P) MAGNESIUM HYDROXIDE270 mg
    DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE80 mg
    Inactive Ingredients
    Ingredient NameStrength
    ADIPIC ACID (UNII: 76A0JE0FKJ)  
    CROSPOVIDONE (UNII: 2S7830E561)  
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    Product Characteristics
    ColorpinkScoreno score
    ShapeROUNDSize20mm
    FlavorBERRY, GINGERImprint Code M1Y
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62372-552-5050 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/04/202102/28/2025
    2NDC:62372-552-5150 in 1 BOTTLE; Type 0: Not a Combination Product08/16/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00105/04/2021
    Labeler - Infirst Healthcare Inc. (079159739)